Response to: Prognosis of metastatic bone cancer and myeloma patients and long‑term risk of medication‑related osteonecrosis of the jaw (MRONJ): some critical points.

Hironobu Hata Kenji Imamachi Michihiro Ueda Masashi Matsuzaka Hiroaki Hiraga Toshihisa Osanai Toru Harabayashi Katsuya Fujimoto Satoshi Oizumi Masato Takahashi Kazuhito Yoshikawa Jun Sato Yutaka Yamazaki Yoshimasa Kitagawa

Support Care Cancer

Department of Oral Pathobiological Science, Faculty of Dental Medicine, Oral Diagnosis and Medicine, Hokkaido University, Nishi 7-Tyoume Kita 13-Jyo, Kita-Ku, Sapporo, 060-8586, Japan.

Published: December 2022

Download full-text PDF	Source
http://dx.doi.org/10.1007/s00520-022-07434-3	DOI Listing

Publication Analysis

Top Keywords

response prognosis

prognosis metastatic

metastatic bone

bone cancer

cancer myeloma

myeloma patients

patients long‑term

long‑term risk

risk medication‑related

medication‑related osteonecrosis

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!